Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul:138:108715.
doi: 10.1016/j.jsat.2021.108715. Epub 2022 Jan 10.

Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing

Barbara Andraka-Christou  1 , Adam J Gordon  2 , Joanne Spetz  3 , Rachel Totaram  4 , Matthew Golan  5 , Olivia Randall-Kosich  6 , Jordan Harrison  7 , Spencer Calder  2 , Stefan G Kertesz  8 , Bradley D Stein  7
Affiliations

Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing

Barbara Andraka-Christou et al. J Subst Abuse Treat. 2022 Jul.

Abstract

Background: Buprenorphine is a life-saving medication for people with opioid use disorder (OUD). U.S. federal law allows advanced practice clinicians (APCs), such as nurse practitioners (NPs) and physician assistants (PAs), to obtain a federal waiver to prescribe buprenorphine in office-based practices. However, states regulate APCs' scope of practice (SOP) variously, including requirements for physician supervision. States may also have laws entirely banning NP/PA buprenorphine prescribing or requiring that supervising physicians have a federal waiver to prescribe buprenorphine. We sought to identify prevalence of state laws other than SOP laws that either 1) prohibit NP/PA buprenorphine prescribing entirely, or 2) require supervision by a federally waivered physician.

Methods: We searched for state statutes and regulations in all 50 states and Washington D.C. regulating prescribing of buprenorphine for OUD by APCs during summer 2021. We excluded general scope of practice laws, laws only applicable to Medicaid-funded clinicians, laws not applicable to substance use disorder (SUD) treatment, and laws only applicable to NPs/PAs serving licensed SUD treatment facilities. We then conducted content analysis.

Results: One state prohibits all APCs from prescribing buprenorphine for OUD, even though the state's general SOP laws permit APC buprenorphine prescribing. Five states require PA supervision by a federally waivered physician. Three states require NP supervision by a federally waivered physician.

Conclusions: Aside from general scope of practice laws, several states have created laws explicitly regulating buprenorphine prescribing by APCs outside of licensed state SUD facilities.

Keywords: Advanced care practitioners; Buprenorphine; Collaboration; Medications for opioid use disorder; Nurse practitioners; Opioid use disorder; Physician assistants; Scope of practice; State law; Supervision; Waiver.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST:

Authors have no conflict of interest to report.

Figures

Fig. 1:
Fig. 1:
NP PA paper.
See this image and copyright information in PMC

References

    1. Ahmad F, Rossen L, Spencer M, Warner M, & Sutton P (2021). Provisional drug overdose death counts. National Center for Health Statistics. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm#citation
    1. Andrilla CHA, Jones KC, & Patterson DG (2020). Prescribing Practices of Nurse Practitioners and Physician Assistants Waivered to Prescribe Buprenorphine and the Barriers They Experience Prescribing Buprenorphine. The Journal of Rural Health, 36(2), 187–195. 10.1111/jrh.12404 - DOI - PubMed
    1. Andrilla CHA, & Patterson DG (2021). Tracking the geographic distribution and growth of clinicians with a DEA waiver to prescribe buprenorphine to treat opioid use disorder. The Journal of Rural Health. 10.1111/jrh.12569 - DOI - PubMed
    1. Andrilla CHA, Patterson DG, Moore TE, Coulthard C, & Larson EH (2018). Projected Contributions of Nurse Practitioners and Physicians Assistants to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas. Medical Care Research and Review, 77(2), 2018–2216. 10.1177/1077558718793070 - DOI - PubMed
    1. Barnett ML, Lee D, & Frank RG (2019). In Rural Areas, Buprenorphine Waiver Adoption Since 2017 Driven By Nurse Practitioners And Physician Assistants. Health Affairs, 38(12), 2048–2056. 10.1377/hlthaff.2019.00859 - DOI - PMC - PubMed

Publication types